Principal Investigator/Professor of Genetics
QBRI/Hamad Bin Khalifa University
Dr. Albagha received a BSc degree (with distinction) in Medical Technology from the University of Jordan in 1996 and then he moved to the UK where he obtained an MSc in Medical Molecular Genetics from the University of Aberdeen in 1997. He was awarded a PhD scholarship to investigate genetic loci influencing susceptibility to osteoporosis at the University of Aberdeen. After completing his PhD degree in 2001, he worked as a postdoctoral researcher investigating the genetic determinants of osteoporosis until 2002 when he was appointed as an Arthritis Research UK lecturer (Assistant Professor) in Genetics of Bone disease at the Institute of Medical Sciences, University of Aberdeen, UK. In 2005 he moved to the University of Edinburgh as a Principal Investigator/Group leader at the Centre for Genomic and Experimental Medicine (CGEM). In 2014, he was appointed the Associate Director of the Paget’s Association Centre of Excellence, Edinburgh. In early 2017, he joined Qatar Biomedical Research Institute as a Principal investigator and Professor of Genetics at Hamad Bin Khalifa University. His current research focuses on Genomic Medicine aiming at understanding the genetic determinants of complex disease with emphasis on Type 2 Diabetes, and Autism. He has active collaborations with Qatar Genome Project to investigate genetics of disease-related traits in Qatar. He has published in high impact journals (Nature Genetics, JAMA, Cell Reports, and JBMR,..) and his work has been featured in news outlets such as the BBC and other international media. Dr Albagha has received many awards from international organizations including the European Calcified Tissue Society (ECTS) and the American Society for Bone and Mineral Research (ASBMR). He has obtained multiple research grants totaling over US$ 6 million including the highly prestigious European Research Council (ERC) Consolidator fellowship.